SUBSCRIBE
SUBSCRIBE
News   Business

XOMA Ltd. Chief Financial Officer David Boyle II Resigns to Join Another Biotech Firm

July 28, 2008 | 
1 min read
BOSTON, Jul 28, 2008 (Thomson Financial via COMTEX) -- XOMA Ltd. Monday said David Boyle II, vice president of finance and chief financial officer, has resigned from the company to join another biotechnology company.
People
MORE ON THIS TOPIC
Illustration with office chair concept with many chairs knocked over
Layoffs
TScan cuts 75% of workforce while shifting focus to solid tumor program
September 3, 2026
 · 
2 min read
 · 
Angela Gabriel
Funds help overcome the financial crisis. Business team crossing banknote bridge vector
Funding
US to grant up to $125M for personalized RNA manufacturing innovation
September 3, 2026
 · 
2 min read
 · 
Michael Gibney
Trustworthy and honesty to believe in work together, integrity or trust for partnership, support and reliable to help success together concept, businessman acrobat hold hand tight by trusted partner.
Deals
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
September 3, 2026
 · 
1 min read
 · 
Tristan Manalac
FDA
Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals
September 2, 2026
 · 
2 min read
 · 
Jef Akst